Literature DB >> 10372663

Clinical review 106: Amenorrheic bone loss.

K K Miller1, A Klibanski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10372663     DOI： 10.1210/jcem.84.6.5688

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  18 in total

1.  Hyperprolactinaemia caused by antipsychotic drugs.

Authors:  Angelika Wieck; Peter Haddad
Journal:  BMJ       Date:  2002-02-02

Review 2.  Adolescence: the period of dramatic bone growth.

Authors:  Connie M Weaver
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

3.  Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.

Authors:  D Holmberg-Marttila; A Leino; H Sievänen
Journal:  Osteoporos Int       Date:  2003-02-12       Impact factor: 4.507

Review 4.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

5.  Predictive factors of change in BMD at 1 and 2 years in women with anorexia nervosa: a study of 146 cases.

Authors:  I Legroux-Gérot; J Vignau; M d'Herbomez; R-M Flipo; B Cortet
Journal:  Osteoporos Int       Date:  2012-02-17       Impact factor: 4.507

Review 6.  Dietary recommendations and athletic menstrual dysfunction.

Authors:  Melinda M Manore
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

7.  Preadipocyte factor-1 levels are higher in women with hypothalamic amenorrhea and are associated with bone mineral content and bone mineral density through a mechanism independent of leptin.

Authors:  Konstantinos N Aronis; Holly Kilim; John P Chamberland; Anne Breggia; Clifford Rosen; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2011-07-27       Impact factor: 5.958

8.  Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats.

Authors:  Chiaming Fan; Kristen R Georgiou; Ross A McKinnon; Dorothy M K Keefe; Peter R C Howe; Cory J Xian
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

9.  Osteoporosis in patients with subclinical hypothyroidism treated with thyroid hormone.

Authors:  Pedro J Tárraga López; Carmen Frias López; Francisco Naharro de Mora; José Antonio Rodríguez Montes; Juan Solera Albero; Antonio Naharro Mañez; Arancha Galvez Casas
Journal:  Clin Cases Miner Bone Metab       Date:  2011-09

10.  The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.

Authors:  I Kyvernitakis; K Kostev; T Nassour; F Thomasius; P Hadji
Journal:  Osteoporos Int       Date:  2016-07-26       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.